LIGAND PHARMACEUTICALS INVESTOR REMINDER: Hagens Berman Reminds Ligand Pharmaceuticals Investors of Securities Class Action Lead Plaintiff Deadline
December 14, 2016 09:30 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Dec. 14, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in Ligand Pharmaceuticals, Inc. (NASDAQ:LGND) of the January 17, 2017 Lead Plaintiff deadline. ...
LIGAND PHARMACEUTICALS INVESTOR ALERT: Hagens Berman Alerts Ligand Pharmaceuticals Investors to Accounting Restatements, Securities Class Action, and Lead Plaintiff Deadline
November 23, 2016 09:30 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Nov. 23, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in Ligand Pharmaceuticals, Inc. (NASDAQ:LGND) to the securities class action filed in the U.S....